CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CERUS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$2.22+0.04 (+1.83%)
Close on Oct 19, 2026
- Market cap
- $445.25M
- P/E (TTM)
- –
- Dividend yield
- –
Cerus statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Cerus | Industry median |
|---|---|---|
| Market Cap | $447.39M | $230.55M |
| Enterprise Value | $391.81M | $202.97M |
| PB Ratio | 6.39 | 3.04 |
| P/TBV Ratio | 6.51 | 4.43 |
| P/OCF Ratio | 185.10 | 22.47 |
Enterprise value
| Measure | Cerus | Industry median |
|---|---|---|
| EV / EBITDA | 5936.55 | 19.74 |
Income (trailing twelve months)
| Measure | Cerus | Industry median |
|---|---|---|
| Operating Income | -$1.62M | -$4.31M |
| Pretax Income | -$6.44M | -$2.37M |
| Net Income | -$6.78M | -$6.57M |
| EBITDA | $66.00K | -$1.98M |
| EPS (Diluted) | -$0.03 | -$0.08 |
Returns
| Measure | Cerus | Industry median |
|---|---|---|
| Return on Equity (ROE) | -10.8% | -18.2% |
| Return on Assets (ROA) | -3.24% | -13.3% |
| Return on Capital Employed (ROCE) | -1.35% | -9.07% |
Growth
| Measure | Cerus | Industry median |
|---|---|---|
| FCF Growth (YoY) | -153.4% | 9.68% |
| Revenue Growth (3Y CAGR) | 7.48% | 7.08% |
| Revenue Growth (5Y CAGR) | 15.4% | 11.8% |
Balance sheet
| Measure | Cerus | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $56.26M | $36.66M |
| Net Cash (Debt) | $56.26M | $3.92M |
| Net Cash Per Share | $0.28 | $0.28 |
| Equity (Book Value) | $70.02M | $55.33M |
| Book Value Per Share | $0.35 | $2.87 |
| Tangible Book Value | $68.71M | $10.79M |
| Working Capital | $71.52M | $56.72M |
Financial position
| Measure | Cerus | Industry median |
|---|---|---|
| Current Ratio | 1.83 | 2.48 |
| Quick Ratio | 1.02 | 1.53 |
| Interest Coverage | -0.21 | -1.85 |
Cash flow (trailing twelve months)
| Measure | Cerus | Industry median |
|---|---|---|
| Operating Cash Flow | $2.42M | -$566.22K |
| Capital Expenditures | -$4.25M | -$3.69M |
| Free Cash Flow | -$1.83M | -$696.00K |
| FCF Per Share | -$0.01 | -$0.02 |
Efficiency
| Measure | Cerus | Industry median |
|---|---|---|
| Profits Per Employee | -$24.67K | -$51.88K |
| Employee Count | 275 | 185 |
Dividends and yields
| Measure | Cerus | Industry median |
|---|---|---|
| Earnings Yield | -1.52% | -6.88% |
| FCF Yield | -0.41% | -0.45% |
| Buyback Yield | 0.00% | 0.78% |
| Shareholder Yield | 0.00% | 0.80% |
Shares
| Measure | Cerus | Industry median |
|---|---|---|
| Shares Outstanding | 201,525,000 | 44,302,700 |
| Shares Change (YoY) | 3.89% | 3.36% |
| Float | 189,508,000 | 37,462,700 |
| Shares Held by Insiders | 5.96% | 10.5% |
| Shares Held by Institutions | 74.8% | 63.5% |
Taxes
| Measure | Cerus | Industry median |
|---|---|---|
| Income Tax | $390.00K | $1.52M |
Scores
| Measure | Cerus | Industry median |
|---|---|---|
| Altman Z-Score | -5.02 | 1.95 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Cerus's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.